Lantheus Holdings, Inc. (LNTH) stock
Close on Nov 11, 2026Market cap $6.63BP/E 25.1Yield –
Lantheus Holdings, Inc. grew revenue 2.4% to $1.56B over the twelve months to Sep 30, 2026. Operating income fell 16.3% to $290.93M, moving the operating margin from 22.8% to 18.6%. At the latest close the market valued the company at $6.63B, 25.1 times its earnings.
Key statistics
Valuation at the latest close; fundamentals over the trailing twelve months, balances at Sep 30, 2026
Valuation
- Market cap
- $6.63B
- P/E ratio
- 25.1
- Price to sales
- 4.25
- Price to book
- 4.89
- Dividend yield
- –
- Free cash flow yield
- –
Fundamentals
- Revenue
- $1.56B
- Net income
- $269.91M
- EPS, diluted
- $4.05
- Book value per share
- $19.82
- Diluted shares
- 68M
Trading
- Next earnings
- Feb 25, 2027 (estimated, before the open)
- Previous close
- $101.62
- Open
- $101.62
- Day's range
- $101.39 – $101.70
- Volume
- 1,021,044
- Average volume (20 days)
- 1,099,041
- Index membership
- S&P MidCap 400 (since Nov 2022), Russell 2000, Russell 3000
- Beta (5 years)
- 0.70
- 52-week range
- $50.69 – $111.86
- RSI (14 days)
- 66.4
- Volatility (1 year)
- 30.8%
- Relative volume
- 0.82×
- WACC
- 8.0%
Index membership is inferred from the holdings of funds that track each index (IJH, SPMD, IWM, IWV), as reported to the SEC for Jun 30, 2026. Join dates come from quarterly fund reports since 2019, so they are accurate to the quarter.
Market cap history
Month-end market cap since 2015, using shares outstanding reported at the time
Total return vs. the S&P 500
Price change plus reinvested dividends, to the close on Nov 11, 2026. The S&P 500 is measured by the SPY fund.
| Period | LNTH | S&P 500 | Difference | LNTH per year | S&P 500 per year |
|---|---|---|---|---|---|
| 1 month | +1.4% | -2.4% | +3.9 pts | ||
| 3 months | +0.9% | -1.2% | +2.1 pts | ||
| Year to date | +52.7% | +12.3% | +40.4 pts | ||
| 1 year | +90.4% | +12.4% | +77.9 pts | ||
| 3 years | +60.1% | +78.8% | −18.7 pts | +17.0% | +21.4% |
| 5 years | +239.1% | +75.2% | +164.0 pts | +27.7% | +11.9% |
| 10 years | +931.5% | +311.1% | +620.4 pts | +26.3% | +15.2% |
Fourteen years at a glance
Fiscal years 2012 to 2025 and trailing twelve months, USD
Revenue
Gross profit
Operating income
Net income
EPS, diluted
Free cash flow
Press releases
Releases Lantheus filed with the SEC as exhibits to Form 8-K or 6-K
- Results
- Results
- Update
- Update
- Results
- Results
About Lantheus
In Vitro & In Vivo Diagnostic Substances
Lantheus Holdings, Inc. develops, manufactures, and commercializes diagnostic imaging agents and radiopharmaceuticals. The company operates primarily through its radiopharmaceutical oncology and precision diagnostics businesses. Its commercial products include PYLARIFY, an imaging agent used in positron emission tomography scans, DEFINITY, an injectable imaging product, and Neuraceq. In addition, the business develops product candidates such as MK-6240 and NAV-4694. Lantheus serves healthcare providers, clinical development partners, and medical facilities that operate imaging equipment and diagnostic technologies.
Company profile, executives and historyLantheus stock: common questions
What is Lantheus's stock price?
LNTH closed at $101.60 on Nov 11, 2026, down 0.02% on the day. Over the past 52 weeks it traded between $50.69 and $111.86.
What is Lantheus's market cap?
Lantheus was worth $6.63B at the close on Nov 11, 2026: the share price times the diluted shares outstanding.
What is LNTH's P/E ratio?
LNTH trades at 25.1 times earnings, based on diluted earnings per share of $4.05 over the twelve months to Sep 30, 2026.
How much revenue does Lantheus make?
Lantheus reported revenue of $1.56B for the twelve months to Sep 30, 2026, up 2.4% from a year earlier.
Does Lantheus pay a dividend?
No. Lantheus has not paid a cash dividend over the last twelve months.
When does Lantheus report earnings next?
Lantheus is expected to report Q4 FY2026 results on Feb 25, 2027, before the open. The date is estimated from its past reporting pattern until the company confirms it.
How has LNTH stock performed over the past year?
Including dividends, LNTH returned +90.4% over the past year, against +12.4% for the S&P 500.
How many LNTH shares are sold short?
4M shares were sold short at the latest FINRA report, 5.71% of the float, or 3.2 days of average trading volume.
Who are Lantheus's competitors?
Companies most similar to Lantheus by business, industry and size include QDEL, NEOG, MYGN, IDXX, TLX.
See a number that looks wrong?